Overview

To Study the Effect of Vytorin on Intracellular Lipid and Inflammation in Obese Subjects

Status:
Unknown status
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
This study focuses on the use of Vytorin to study inflammatory markers in subjects with normal cholesterol.
Phase:
Phase 3
Details
Lead Sponsor:
Kaleida Health
Treatments:
Ezetimibe, Simvastatin Drug Combination
Simvastatin